FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to paediatrics, allergology and pulmonology, and can be used for treating bronchial asthma (BA) with persistent cytomegalovirus (CMV) in children. For this purpose after the signs of persistent CMV have been detected in bronchi, including its DNA fragments in expectorations, human immunoglobulin titred by CMV antibody count is immediately prescribed according to the scheme of 1.5 ml intramuscularly every third day within the course of 5 injections.
EFFECT: method enables relieving the clinical course of BA with a reduced extent of a baseline therapy.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREVENTING DEVELOPMENT OF UNCONTROLLED BRONCHIAL ASTHMA FORMS INDUCED BY MANGANESE AND VANADIUM IMPACT IN CHILDREN OVER 5 YEARS OLD | 2014 |
|
RU2555341C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
METHOD FOR PREVENTING PARTIALLY CONTROLLED BRONCHIAL ASTHMA CAUSED BY MANGANESE AND VANADIUM EXPOSURE IN CHILDREN AGED 5 AND OLDER | 2014 |
|
RU2546525C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
METHOD OF PROGNOSIS OF EFFICIENCY OF BRONCHIAL ASTHMA BASIC THERAPY IN CHILDREN | 2007 |
|
RU2356054C1 |
METHOD FOR PREVENTION OF EXACERBATION OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2625744C1 |
METHOD OF ESTIMATING LEVEL OF BRONCHIAL ASTHMA CONTROL IN CHILDREN | 2011 |
|
RU2458634C1 |
METHOD FOR PREVENTING EXACERBATIONS OF BRONCHIAL ASTHMA | 2003 |
|
RU2252785C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA, EITHER INTERMITTENT, OR MIXED OF MILD SEVERITY LEVEL | 2006 |
|
RU2345774C2 |
METHOD OF DETERMINATION OF INDICATIONS TO PREVENTIVE INCREASE OF VOLUME OF BASIC THERAPY BY GLUCOCORTICOSTEROIDS INHALATION AT CHILDREN WITH BRONCHIAL ASTHMA AGAINST JOINING OF ACUTE RESPIRATORY INFECTION | 2007 |
|
RU2365338C2 |
Authors
Dates
2014-04-27—Published
2012-08-14—Filed